Table 4 Univariable logistic regression analysis of risk factors for regional nodal recurrences superior to the ESTRO supraclavicular CTV (CTV4) or in the RADCOMP Posterior Neck CTV in patients who were treated for node-positive breast cancer (n = 33)
From: PET/CT of breast cancer regional nodal recurrences: an evaluation of contouring atlases
Baseline Variable | Odds ratio | 95% confidence interval | p-value |
|---|---|---|---|
Lymphovascular invasion* | |||
 Yes vs No | 1.8 | 0.3–10.9 | 0.52 |
Grade* | |||
 3 vs 1 & 2 | 0.6 | 0.1–3.0 | 0.56 |
Stage* | |||
 III vs I & II | 3.3 | 0.4–29.0 | 0.28 |
Adjuvant regional nodal radiotherapy | |||
 Yes vs No | 0.7 | 0.1–3.5 | 0.63 |
Type of relapse | |||
 Metastatic & RNR vs RNR only | 0.6 | 0.1–3.0 | 0.56 |